ACL vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

52MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

ACL MVP
Technical
49
68
Catalyst
53
50
Sentiment
50
50
Fundamental
85
95
Momentum
58
51
Risk Gate
43
50

Key Metrics

ACL Metric MVP
$505.5MMarket Cap$52.9M
1.1MAvg Volume (20d)214K
+5.0%Short InterestN/A
$3.03052-Week High$0.765
$1.83352-Week Low$0.365
+0.0%Daily Change+2.2%
$2.710Reference Price$0.460
+14.9%ROE+1.1%
+3.2%Profit Margin+1.5%

Active Signals

ACL Signals

●MACD momentum is losing steam
●Drifting lower — down 3.2% over the last 5 days
●Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (0.7x)
●EPS estimates revised upward (+10pts)
●Earnings declining (-12% QoQ)

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ACL and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AHC vs CMP →AHC vs PIQ →ARX vs EYE →ATH vs ATX →ATH vs BLS →
ACL Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).